Literature DB >> 29610749

New insight into type 1 diabetes development: resolving early diabetogenic CD4+ T cell responses that precede seroconversion.

Sonja Schallenberg1, Karsten Kretschmer1,2,3.   

Abstract

Entities:  

Year:  2018        PMID： 29610749      PMCID： PMC5879518          DOI： 10.21037/atm.2017.12.14

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  17 in total

Review 1.  Genetics, pathogenesis and clinical interventions in type 1 diabetes.

Authors:  Jeffrey A Bluestone; Kevan Herold; George Eisenbarth
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

2.  Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial.

Authors:  Ezio Bonifacio; Anette-G Ziegler; Georgeanna Klingensmith; Edith Schober; Polly J Bingley; Marietta Rottenkolber; Anke Theil; Anne Eugster; Ramona Puff; Claudia Peplow; Florian Buettner; Karin Lange; Jörg Hasford; Peter Achenbach
Journal:  JAMA       Date:  2015-04-21       Impact factor: 56.272

3.  Transplantation of human islets without immunosuppression.

Authors:  Barbara Ludwig; Andreas Reichel; Anja Steffen; Baruch Zimerman; Andrew V Schally; Norman L Block; Clark K Colton; Stefan Ludwig; Stephan Kersting; Ezio Bonifacio; Michele Solimena; Zohar Gendler; Avi Rotem; Uriel Barkai; Stefan R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

4.  Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up.

Authors:  Natalia Marek-Trzonkowska; Małgorzata Myśliwiec; Anita Dobyszuk; Marcelina Grabowska; Ilona Derkowska; Jolanta Juścińska; Radosław Owczuk; Agnieszka Szadkowska; Piotr Witkowski; Wojciech Młynarski; Przemysława Jarosz-Chobot; Artur Bossowski; Janusz Siebert; Piotr Trzonkowski
Journal:  Clin Immunol       Date:  2014-04-01       Impact factor: 3.969

5.  Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.

Authors:  Anette G Ziegler; Marian Rewers; Olli Simell; Tuula Simell; Johanna Lempainen; Andrea Steck; Christiane Winkler; Jorma Ilonen; Riitta Veijola; Mikael Knip; Ezio Bonifacio; George S Eisenbarth
Journal:  JAMA       Date:  2013-06-19       Impact factor: 56.272

6.  Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.

Authors:  Mohammad Alhadj Ali; Yuk-Fun Liu; Sefina Arif; Danijela Tatovic; Hina Shariff; Vivienne B Gibson; Norkhairin Yusuf; Roman Baptista; Martin Eichmann; Nedyalko Petrov; Susanne Heck; Jennie H M Yang; Timothy I M Tree; Irma Pujol-Autonell; Lorraine Yeo; Lucas Baumard; Rachel Stenson; Alex Howell; Alison Clark; Zoe Boult; Jake Powrie; Laura Adams; Florence S Wong; Stephen Luzio; Gareth Dunseath; Kate Green; Alison O'Keefe; Graham Bayly; Natasha Thorogood; Robert Andrews; Nicola Leech; Frank Joseph; Sunil Nair; Susan Seal; HoYee Cheung; Craig Beam; Robert Hills; Mark Peakman; Colin M Dayan
Journal:  Sci Transl Med       Date:  2017-08-09       Impact factor: 17.956

Review 7.  Immune mechanisms in type 1 diabetes.

Authors:  Maja Wållberg; Anne Cooke
Journal:  Trends Immunol       Date:  2013-09-18       Impact factor: 16.687

8.  Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study.

Authors:  Sandra Hummel; Maren Pflüger; Michael Hummel; Ezio Bonifacio; Anette-G Ziegler
Journal:  Diabetes Care       Date:  2011-04-22       Impact factor: 19.112

9.  Foxp3(+) regulatory T cells in mouse models of type 1 diabetes.

Authors:  Cathleen Petzold; Julia Riewaldt; Deepika Watts; Tim Sparwasser; Sonja Schallenberg; Karsten Kretschmer
Journal:  J Diabetes Res       Date:  2013-03-14       Impact factor: 4.011

10.  Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity.

Authors:  Federica Barzaghi; Laura Passerini; Rosa Bacchetta
Journal:  Front Immunol       Date:  2012-07-31       Impact factor: 7.561
View more
  2 in total

Review 1.  Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes.

Authors:  Wei Hu; Xiang Song; Haibo Yu; Jingyu Sun; Hongjun Wang; Yong Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-12       Impact factor: 5.555

Review 2.  Insights From Single Cell RNA Sequencing Into the Immunology of Type 1 Diabetes- Cell Phenotypes and Antigen Specificity.

Authors:  Stephanie J Hanna; Danijela Tatovic; Terri C Thayer; Colin M Dayan
Journal:  Front Immunol       Date:  2021-10-01       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.